ATE497970T1 - Inhibitor des uracil-dna-glycosylaseenzyms und anwendungen davon - Google Patents

Inhibitor des uracil-dna-glycosylaseenzyms und anwendungen davon

Info

Publication number
ATE497970T1
ATE497970T1 AT06841794T AT06841794T ATE497970T1 AT E497970 T1 ATE497970 T1 AT E497970T1 AT 06841794 T AT06841794 T AT 06841794T AT 06841794 T AT06841794 T AT 06841794T AT E497970 T1 ATE497970 T1 AT E497970T1
Authority
AT
Austria
Prior art keywords
uracil
zyme
inhibitor
dna glycosylase
glycosylase
Prior art date
Application number
AT06841794T
Other languages
English (en)
Inventor
De Las Heras Gemma Serrano
Garcia Alicia Bravo
Falgueras Margarita Salas
Original Assignee
Consejo Superior Investigacion
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consejo Superior Investigacion filed Critical Consejo Superior Investigacion
Application granted granted Critical
Publication of ATE497970T1 publication Critical patent/ATE497970T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/01—DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10211—Podoviridae
    • C12N2795/10222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
AT06841794T 2005-12-23 2006-12-01 Inhibitor des uracil-dna-glycosylaseenzyms und anwendungen davon ATE497970T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200503240A ES2304833B1 (es) 2005-12-23 2005-12-23 Inhibidor de la enzima uracil dna glicosilasa y aplicaciones.
PCT/ES2006/070187 WO2007074200A1 (es) 2005-12-23 2006-12-01 Inhibidor de la enzima uracil dna glicosilasa y aplicaciones

Publications (1)

Publication Number Publication Date
ATE497970T1 true ATE497970T1 (de) 2011-02-15

Family

ID=38217718

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06841794T ATE497970T1 (de) 2005-12-23 2006-12-01 Inhibitor des uracil-dna-glycosylaseenzyms und anwendungen davon

Country Status (8)

Country Link
US (2) US20100120675A1 (de)
EP (1) EP1970380B1 (de)
JP (1) JP2009520487A (de)
AT (1) ATE497970T1 (de)
DE (1) DE602006020073D1 (de)
DK (1) DK1970380T3 (de)
ES (2) ES2304833B1 (de)
WO (1) WO2007074200A1 (de)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4672053A (en) 1982-12-14 1987-06-09 Obrig Tom G Immunoaffinity purification of phytolaccin proteins and their use in treating Herpes Simplex virus type II

Also Published As

Publication number Publication date
DE602006020073D1 (de) 2011-03-24
EP1970380A1 (de) 2008-09-17
US20120040890A1 (en) 2012-02-16
DK1970380T3 (da) 2011-04-18
ES2304833B1 (es) 2009-10-21
ES2360370T3 (es) 2011-06-03
US8129336B1 (en) 2012-03-06
US20100120675A1 (en) 2010-05-13
EP1970380B1 (de) 2011-02-09
ES2304833A1 (es) 2008-10-16
WO2007074200A1 (es) 2007-07-05
JP2009520487A (ja) 2009-05-28

Similar Documents

Publication Publication Date Title
DK1954807T3 (da) I-CreI-homing-endonukleasevarianter med hidtil ukendt kløvningsspecificitet og anvendelse deraf
EA200702358A1 (ru) Комбинация ингибитора pde4 и производного тетрагидробиоптерина
WO2007022459A3 (en) Processes and intermediates
CY1112630T1 (el) Αναστολεις πυριδυλιου της σηματοδοτησης hedgehog
DE602006016150D1 (de) Vorbeugung von krankheiten bei kaiserschnitt-babies
IL185494A0 (en) Purification of cinacalcet
DE602007009663D1 (de) Pyridonsulfonamide und pyridonsulfamide als mek-hemmer
ATE441639T1 (de) 2,4-diamino-pyrimidine als aurora inhibitoren
DK1848718T3 (da) E1 aktiveringsenzymhæmmere
EA200701122A1 (ru) Потенциаторы рецепторов глутамата
ATE550037T1 (de) Zusammensetzungen gegen das sars-coronavirus und ihre verwendungen
EA200801739A1 (ru) Индолопиридины в качестве модуляторов кинезина eg5
DE602006020327D1 (de) 2-phenoxy-n-(1,3,4-thiadizol-2-yl)pyridin-3-aminder-hemmer zur behandlung thromboembolischer erkrankungen
EA201000948A1 (ru) Ингибиторы вирусной полимеразы
EA200801852A1 (ru) Индолопиридины в качестве модуляторов кинезина eg5
NO20082298L (no) Kaliumkanalinhibitorer
NO20073368L (no) Amid-promedikament av gemcitabin, sammensetninger og anvendelse derav
EP2296693A4 (de) Zusammensetzungen zur verstärkung der antibakteriellen wirkung von myeloperoxidase und anwendungsverfahren davon
WO2008048121A3 (en) Macrocyclic cysteine protease inhibitors and compositions thereof
ITTO20040266A1 (it) Robot industriale
TW200744567A (en) Phenylethylamine analogs and their use for treating glaucoma
DE602005003404D1 (de) Brechhammer und Befestigungselement, Seitenplatte und Schutzgehäuse des Brechhammers
MX2010010876A (es) Piperidinas sustituidas como compuestos terapeuticos.
DE602005015774D1 (de) Industrieroboter
EA200800070A1 (ru) Производные 2-(1h-индолилсульфанил)ариламина

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties